Médulloblastomes de l’enfant

, par  Anthony Joud , Jean-Claude Marchal , Olivier Klein, Pascal Chastagner , Pierre-Henri Pretat , Valérie Bernier-Chastagner , popularité : 6%
[English] [français]
Pathologies |

Bibliographie

  • 1. Abadie C, Gauthier-Villars M, Sirvent N, Coupier I. Genetic predisposition to childhood cancer. Arch Pediatr 2012 ;19:863-75. 2B
  • 2. Bailey C., Gnekow A., Wellek S., Jones M., Round C., Brown J., et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO) : SIOP II Med Pediatr Oncol 1995 ; 25:166-78. 2B
  • 3. Bailey P, Cushing H. Medulloblastoma Cerebelli : a common type of midcerebellar glioma of childhood. Arch Neurol & Psychiat 1925 ;14:192-223. C
  • 4. Boiardi A, Silvani A, Eoli M, Fariselli L, Zappacosta B, Salmaggi A. Embryonal tumors in the adult population : implications in therapeutic planning. Neurol Sci 2000 ;21(1):23-30. 2B
  • 5. Bourdeaut F, Miquel C, Alapetite C, Roujeau T, Doz F. Medulloblastomas : update on a heterogeneous disease. Curr Opin Oncol 2011 ;23(6) :630-7. A
  • 6. Brasme JF, Chalumeau M, Doz F, Lacour B, Valteau-Couanet D, Gaillard S, et al. Interval between onset of symptoms and diagnosis of medulloblastoma in children : distribution and determinants in a population-based study. Eur J Pediatr 2012 ;171:25-32. C
  • 7. Brinkman TM, Liptak CC, Delaney BL, Chordas CA, Muriel AC, Manley PE. Suicide ideation in pediatric and adult survivors of childhood brain tumors. J Neurooncol 2013 ;113(3):425-32. 2B
  • 8. Brown HG, Kepner JL, Perlman EJ, Friedman HS, Strother DR, Duffner PK, et al. "Large cell/anaplastic" medulloblastomas : a Pediatric Oncology Group Study. J Neuropathol Exp Neurol 2000 ;59:857-65. 2B
  • 9. Brugières L, Pierron G, Chompret A, Paillerets BB, Di Rocco F, Varlet P, et al. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J Med Genet. 2010 ;47:142-4. 2B
  • 10. Carrie C, Hoffstetter S, Gomez F, Moncho V, Doz F, Alapetite C, et al. Impact of targeting deviations on outcome in medulloblastoma : study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 1999 ;45:435-9.A
  • 11. Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, et al. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma : long-term results of MSFOP 98. J Clin Oncol 2009 ;27:1879-83. B
  • 12. Chang CH, Housepian EM, Herbert C Jr. An operative staging and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969 ;93(6):1351-9. C
  • 13. Chastagner P, Bouffet E, Grill J, Kalifa C. What have we learnt from previous phase II trials to help in the management of childhood tumours ? Eur J Cancer 2001 ;37:1981-93. A
  • 14. Cushing H. Experiences with the cerebellar medulloblastomas. Acta path et microbiol Scand 1930 ;7:1-86. C
  • 15. Deshmukh VR, Figueiredo EG, Deshmukh P, Crawford NR, Preul MC, Spetzler RF. Quantification and comparison of telovelar and transvermian approaches to the fourth ventricle. Neurosurgery 2006 ; 58(4 Suppl 2):ONS-202-6. C
  • 16. Duffner PK, Cohen ME. Long-term consequences of CNS treatment for childhood cancer, Part II : Clinical consequences. Pediatr Neurol 1991 ;7:237-42. C
  • 17. Duffner PK, Cohen ME, Voorhess ML, MacGillivray MH, Brecher ML, Panahon A, et al. Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study. Cancer 1985 ;56:2189-93. 2B
  • 18. Dufour C, Beaugrand A, Pizer B, Micheli J, Aubelle MS, Fourcade A, et al. Metastatic Medulloblastoma in Childhood : Chang’s Classification Revisited. Int J Surg Oncol 2012 ;2012:245385. C
  • 19. Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, et al. Beta-catenin status predicts a favorable outcome in childhood medulloblastoma : the United Kingdom Children’s Cancer Study Group Brain Tumour Committee. J Clin Oncol 2005 ;23(31):7951-7. B
  • 20. Entz-Werle N, Carli ED, Ducassou S, Legrain M, Grill J, Dufour C. Medulloblastoma : what is the role of molecular genetics ? Expert Rev Anticancer Ther 2008 ;8(7):1169-81. B
  • 21. Fouladi M, Langston J, Mulhern R, Jones D, Xiong X, Yang J, et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors : a late sequela of therapy. J Clin Oncol 2000 ;18:824-31. C
  • 22. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96) : long-term results from a prospective, multicentre trial. Lancet Oncol 2006 ;7(:813-20. A
  • 23. Gerber NU, von Hoff K, von Bueren AO, Treulieb W, Deinlein F, Benesch M, et al. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastome. Eur J Cancer 2012 ;48:2028-2036. C
  • 24. Giangaspero F, Bigner SH, Kleihues J, Pietsch T, Trojanowski JQ. Medulloblastoma. In : Kleihues P, Cavenee WK : World Health Organisation Classification of tumours. Pathology and genetics : Tumours of the nervous system. IARC Press Lyon 2000. A
  • 25. Gilbertson RJ. Medulloblastoma : signalling a change in treatment. Lancet Oncol 2004 ;5(4):209-218. A
  • 26. Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton LN, et al. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 1996 ;34:899-904. B
  • 27. Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars P, Frappaz D, et al. Treatment of medulloblastoma with postoperative chemotherapy alone : an SFOP prospective trial in young children. Lancet Oncol 2005 ;6(8):573-80. A
  • 28. Grill J, Kieffer V, Kalifa C. Measuring the neuro-cognitive side-effects of irradiation in children with brain tumors. Pediatr Blood Cancer 2004, ;42, 452-6. C
  • 29. Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 1999 ;45:137-45. C
  • 30. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, et al. Childhood Cancer Survivor Study. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors : Childhood Cancer Survivor Study. Cancer 2003,97:663-73. C
  • 31. Halperin EC, Watson DM, George SL. Duration duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer 2001 ;91:1444-1450. C
  • 32. Hoppe-Hirsch E, Renier D, Lellouch-Tubiana A, Sainte-Rose C, Pierre-Kahn A, Hirsch JF. Medulloblastoma in childhood : progressive intellectual deterioration. Childs Nerv Syst 1990 ;6:60-5. C
  • 33. Hoppe-Hirsch E, Brunet L, Laroussinie F, Cinalli G, Pierre-Kahn A, Renier D, et al. Intellectual outcome in children with malignant tumors of the posterior fossa : influence of the field of irradiation and quality of surgery. Childs Nerv Syst 1995 ;11:340-5. C
  • 34. Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma : early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2002 ;52:599-605. C
  • 35. Johnson DL, McCabe MA, Nicholson HS, Joseph AL, Getson PR, Byrne J, et al. Quality of long-term survival in young children with medulloblastoma. J Neurosurg 1994 ;80:1004-10. C
  • 36. Kao GD, Goldwein JW, Schultz DJ, Radcliffe J, Sutton L, Lange B. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors. Cancer 1994 ;74:965-71. B
  • 37. Kleihues P, Cavenee WK : World Health Organisation Classification of tumours. Pathology and genetics : Tumours of the nervous system. IARC Press Lyon 2000.
  • 38. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002 ;6(3):215-25. B
  • 39. Kortmann RD, Kuhl J, Timmermann B. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood. Int J Radiat Onocol Biol Phys 2000, 46, 269-79. B
  • 40. Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, et al. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma : results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol 2012 ;30:3187-93. B
  • 41. Levisohn L, Cronin-Golomb A, Schmahmann JD. Neuropsychological consequences of cerebellar tumour resection in children : cerebellar cognitive and affective syndrome in a paediatric population. Brain 2000 ;123:1041-1050. 2B
  • 42. Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series : recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999 ;91:1051-8. B
  • 43. Moeller BJ, Chintagumpala M, Philip JJ, Grosshans DR, McAleer MF, Woo SY, et al. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy. Radiat Oncol. 2011 Jun 2 ;6:58. doi : 10.1186/1748-717X-6-58. 2B
  • 44. Mostow EN, Byrne J, Connelly RR, Mulvihill JJ. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 1991 ;9:592-9. B
  • 45. Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005 ;23(24):5511-9. 2B
  • 46. Mussi AC, Rhoton AL Jr. Telovelar approach to the fourth ventricle : microsurgical anatomy. J Neurosurg. 2000 May ;92(5):812-23. C
  • 47. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011 ;29(11):1408-1414. C
  • 48. Ogilvy-Stuart A, Clayton P, Shalet S. Cranial irradiation and early puberty. J Clin Endrocrinol Metab 1994 ;78,1282-6. C
  • 49. Olshan JS, Gubernick J, Packer RJ, D’Angio GJ, Goldwein JW, Willi SM, et al. The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 1992 ;70:2013-7. C
  • 50. Orliaguet GA, Hanafi M, Meyer PG, Blanot S, Jarreau MM, Bresson D, et al. Is the sitting or the prone position best for surgery for posterior fossa in children ? Paediatr Anaesth 2001 ;11(5):541-7. C
  • 51. Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy : A Children’s Cancer Group Study. J Clin Oncol 1999 ;17:2127-36. 2B
  • 52. Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor : childhood cancer survivor study. J Clin Oncol 2003 ;21:3255-61. 2B
  • 53. Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, et al. Growth hormone replacement therapy in children with medulloblastoma : use and effect on tumor control. J Clin Oncol 2001 ;19:480-7. C
  • 54. Packer RJ, Cogen P, Vezina G, Rorke LB. Medulloblastoma : clinical and biological aspects. Neuro Oncol 1999 ;1(3):232-250. C
  • 55. Puget S, Boddaert N, Viguier D, Kieffer V, Bulteau C, Garnett M, et al. Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumors. Cancer 2009 ;115(6):1338-47. 2B
  • 56. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma : a Children’s Cancer Group study. J Clin Oncol 2001 ;19:3470-6. 2B
  • 57. Roberts RO, Lynch CF, Jones MP, Hart MN. Medulloblastoma : a population-based study of 532 cases. J Neuropathol Exp Neurol 1991 ;50:134-44. 2B
  • 58. Roussel MF, Hatten ME. Cerebellum development and medulloblastoma. Curr Top Dev Biol 2011 ;94:235-82. C
  • 59. Rutka J, Hoffman H. Medulloblastoma : a historical perspective and overview. J Neurooncol 1996 ;29:1-7. C
  • 60. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005 ;352:978-86. A
  • 61. Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, et al. Survival and prognostic factors of early childhood medulloblastoma : an international meta-analysis. J Clin Oncol 2010 ;28:4961-8. A
  • 62. Sadighi Z, Vats T, Khatua S. Childhood medulloblastoma : the paradigm shift in molecular stratification and treatment profile. J Child Neurol 2012 ;27 :1302-7. C
  • 63. Schmahmann JD, Sherman JC. The cerebellar cognitive and affective syndrome. Brain 1998 ;121:561-579. A
  • 64. Shalet SM, Gibson B, Swindell R, Pearson D. Effect of spinal irradiation on growth. Arch Dis Child 1987 ;62:461-4. C
  • 65. Silber JH, Radcliffe J, Peckham V, Perilongo G, Kishnani P, Friedman M, et al. Whole-brain irradiation and decline in intelligence : the influence of dose and age on IQ score. J Clin Oncol 1992 ;10:1390-6. C
  • 66. Stevens MC, Cameron AH, Muir KR, Parkes SE, Reid H, Whitwell H. Descriptive epidemiology of primary central nervous system tumours in children : a population-based study. Clin Oncol (R Coll Radiol) 1991 ;3:323-329. 2B
  • 67. Soelva V, Hernaiz Driever P, Abbushi A, Rueckriegel S, Bruhn H, Eisner W, et al. Fronto-cerebellar fiber tractography in pediatric patients following posterior fossa tumor surgery. Childs Nerv Syst 2013 ; 29(4)597-607. C
  • 68. Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, et al. Low-stage medulloblastoma : final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 2000 ;18:3004-11.2B
  • 69. Torres CF, Rebsamen S, Silber JH, Sutton LN, Bilaniuk LT, Zimmerman RA, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med 1994 ;330:892-5. A
  • 70. Zeilhofer UB, Scheer I, Warmuth-Metz M, Rushing EJ, Pietsch T, Boltshauser E, et al. Natural history of a medulloblastoma : 30 months of wait and see in a child with a cerebellar incidentaloma. Childs Nerv Syst 2013 ;29:1207-1210. C